BioSpace News Archive

Web-based Software Enables a Virtual Filing Cabinet System to Organizations Providing Services to People With Developmental Disabilities and Other Long-Term Services and Supports

Illnesses subsiding, FDA continues to aggressively investigate source and route of contamination to prevent future outbreaks

XELJANZ XR provides adult patients living with moderately to severely active UC the first and only once-daily JAK inhibitor for managing their disease

This dividend is designated as an “eligible dividend” within the meaning of the Income Tax Act

The study enrolled 120 patients. Medicure expects to release top-line data in Q1 of 2020.

Four of seven evaluable patients with HER2-negative, metastatic or locally-advanced unresectable breast cancer achieved a partial response for an objective response rate of 57%

This bipartisan legislation is a bold step toward lowering prescription drug prices and high out-of-pocket costs for millions of older Americans, including our 1.7 million state members.

Mobidiag Ltd., a molecular diagnostics company with complementary platforms that address antimicrobial resistance and other areas of unmet diagnostic need, will host a symposium at the 39th Interdisciplinary Meeting of Anti-Infectious Chemotherapy (RICAI) conference in Paris, from the 16th to 17th of December.

Cancer patients in communities across the U.S. are expected to benefit from increased access to high quality cancer care, with U.S. provider of radiation therapy and integrated cancer treatments, 21st Century Oncology, to become part of Australian cancer and cardiac care company, GenesisCare.

Evidence of human efficacy observed in patients with specific biomarkers and refractory to standard treatments including platinum and other chemotherapeutics